Home/Filings/4/0001127602-25-003955
4//SEC Filing

Gregory Ginger 4

Accession 0001127602-25-003955

CIK 0000875045other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:44 PM ET

Size

15.8 KB

Accession

0001127602-25-003955

Insider Transaction Report

Form 4
Period: 2025-02-06
Gregory Ginger
EVP, Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-07+1,63515,312.101 total
  • Exercise/Conversion

    Common Stock

    2025-02-07+1,80116,633.101 total
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh560$79,15616,073.101 total
  • Award

    Restricted Stock Unit

    2025-02-06+11,24011,240 total
    Exercise: $0.00Exp: 2028-02-06Common Stock (11,240 underlying)
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh480$67,84814,832.101 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-071,6351,635 total
    Exercise: $0.00Exp: 2026-02-08Common Stock (1,635 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-071,8013,604 total
    Exercise: $0.00Exp: 2027-02-07Common Stock (1,801 underlying)
Footnotes (4)
  • [F1]Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2024.
  • [F2]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
  • [F3]The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.
  • [F4]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001545716

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:44 PM ET
Size
15.8 KB